NO872551L - FremgangsmŸte for fremstilling av farmastiske preparater - Google Patents

FremgangsmŸte for fremstilling av farmastiske preparater

Info

Publication number
NO872551L
NO872551L NO872551A NO872551A NO872551L NO 872551 L NO872551 L NO 872551L NO 872551 A NO872551 A NO 872551A NO 872551 A NO872551 A NO 872551A NO 872551 L NO872551 L NO 872551L
Authority
NO
Norway
Prior art keywords
procedure
preparing pharmaceuticals
preparation
pharmaceuticals
preparing
Prior art date
Application number
NO872551A
Other languages
English (en)
Other versions
NO872551D0 (no
Inventor
Hansruedi Surer
Aldo Riva
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO872551D0 publication Critical patent/NO872551D0/no
Publication of NO872551L publication Critical patent/NO872551L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Et farmasøytisk preparat innholdende 4-(l-raetyl-4-piper-idy1iden)-4H-benzo(4,5)cyklohepta(1,2-b)tiofen-10(9H)-on, også kjent som ketotifen, tilpasset for oral tilførsel en gang pr. dag, f.eks. basert på en fettmatriks.Preparatets fremstilling er beskrevet.
NO872551A 1986-06-21 1987-06-18 FremgangsmŸte for fremstilling av farmastiske preparater NO872551L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21

Publications (2)

Publication Number Publication Date
NO872551D0 NO872551D0 (no) 1987-06-18
NO872551L true NO872551L (no) 1987-12-22

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872551A NO872551L (no) 1986-06-21 1987-06-18 FremgangsmŸte for fremstilling av farmastiske preparater

Country Status (30)

Country Link
US (1) US5399360A (no)
JP (2) JPS638332A (no)
KR (1) KR880000095A (no)
AT (1) AT400521B (no)
AU (1) AU611637B2 (no)
BE (1) BE1000661A4 (no)
CA (1) CA1314227C (no)
CH (3) CH672735A5 (no)
CY (1) CY1589A (no)
DE (1) DE3719818C2 (no)
DK (1) DK314387A (no)
ES (1) ES2006170A6 (no)
FI (1) FI872733A (no)
FR (1) FR2600253B1 (no)
GB (1) GB2191696B (no)
GR (1) GR870965B (no)
HK (1) HK27691A (no)
HU (1) HU202753B (no)
IE (1) IE59178B1 (no)
IL (1) IL82924A (no)
IT (1) IT1216822B (no)
LU (1) LU86928A1 (no)
MY (1) MY101566A (no)
NL (1) NL8701335A (no)
NO (1) NO872551L (no)
NZ (1) NZ220769A (no)
PH (1) PH26313A (no)
PT (1) PT85128B (no)
SE (1) SE8702563L (no)
ZA (1) ZA874450B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
US6207684B1 (en) 1997-06-09 2001-03-27 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
WO2001039774A1 (en) * 1999-12-01 2001-06-07 Klein Pharmaceuticals Topical administration of ketotifen
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
NZ555693A (en) * 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2441445A1 (en) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
HUT40568A (en) * 1984-08-16 1987-01-28 Sandoz Ag Process for production of medical preparatives containing ketityphen and xantin-derivatives against asthma
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
LU86928A1 (fr) 1988-01-20
BE1000661A4 (fr) 1989-03-07
ZA874450B (en) 1989-01-25
ES2006170A6 (es) 1989-04-16
CA1314227C (en) 1993-03-09
GB8714131D0 (en) 1987-07-22
FR2600253A1 (fr) 1987-12-24
GR870965B (en) 1987-10-20
NL8701335A (nl) 1988-01-18
CH672735A5 (no) 1989-12-29
IE59178B1 (en) 1994-01-26
DK314387D0 (da) 1987-06-19
CH676201A5 (no) 1990-12-28
AU7452587A (en) 1987-12-24
HUT47428A (en) 1989-03-28
SE8702563D0 (sv) 1987-06-18
GB2191696A (en) 1987-12-23
PH26313A (en) 1992-04-23
KR880000095A (ko) 1988-03-23
NZ220769A (en) 1990-12-21
FI872733A0 (fi) 1987-06-18
PT85128B (pt) 1990-03-30
HU202753B (en) 1991-04-29
DE3719818A1 (de) 1987-12-23
JP2860013B2 (ja) 1999-02-24
IT1216822B (it) 1990-03-14
IE871634L (en) 1987-12-21
DE3719818C2 (de) 1997-02-13
IL82924A (en) 1992-11-15
NO872551D0 (no) 1987-06-18
PT85128A (en) 1987-07-01
SE8702563L (sv) 1987-12-22
AU611637B2 (en) 1991-06-20
JPS638332A (ja) 1988-01-14
CH674805A5 (no) 1990-07-31
CY1589A (en) 1992-04-03
HK27691A (en) 1991-04-19
US5399360A (en) 1995-03-21
IT8748075A0 (it) 1987-06-19
ATA156187A (de) 1995-06-15
FI872733A (fi) 1987-12-22
AT400521B (de) 1996-01-25
MY101566A (en) 1991-12-17
FR2600253B1 (fr) 1990-01-26
GB2191696B (en) 1991-01-16
JPH05246849A (ja) 1993-09-24
IL82924A0 (en) 1987-12-20
DK314387A (da) 1987-12-22

Similar Documents

Publication Publication Date Title
NO872551L (no) FremgangsmŸte for fremstilling av farmastiske preparater
NO174239C (no) Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO870241L (no) Hypoglykemiske tiazolidindioner.
ATE39251T1 (de) 3-(4-piperidyl)-1,2-benzisoxazole, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
DK53285D0 (da) (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme
NO167285C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nafto(1,2-b)-1,4-tiazepinon-derivater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
ATE4203T1 (de) 4-aryloxy- und 4-arylthio-3-phenylpiperidinderivate, verfahren zur herstellung solcher verbindungen und diese enthaltende pharmazeutische zusammensetzungen.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DE3870154D1 (de) Phenol enthaltende, fluessige antitussiv-zusammensetzungen.
FR2456104A1 (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
NO165104C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
NO922635L (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
NO885406D0 (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung
DE3277770D1 (en) The (r,r)-enantiomer of trans-indeno(1,2-b)-1,4-oxazines, process for its preparation and pharmaceutical formulation containing it
SE8107833L (sv) Substituerade tetrahydro-1,2,4-oxadiazin-5-on-derivat med kramplosande verkan, sett for deras framstellning och farmaceutiska beredningar innehallandedem
DK598184A (da) 3-aryl-1,2-benzisoxazolsulfonyl- og -sulfinylalkansyrer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler
ATE79025T1 (de) Formulierung zur herstellung von arzneimitteln mit verzoegerter freisetzung zur oralen gabe.